title: Roles of ApoB-100 gene polymorphisms and the risks of gallstones and gallbladder cancer: a meta-analysis.
abstract: BACKGROUND
  Gallstones (GS) is the major manifestation of gallbladder disease, and is the most common risk factor for gallbladder cancer (GBC). Previous studies investigating the association between ApoB-100 gene polymorphisms and the risks of GS and GBC have yielded conflicting results. Therefore, we performed a meta-analysis to clarify the effects of ApoB-100 gene polymorphisms on the risks of GS and GBC.
  
  
  METHODS
  A computerized literature search was conducted to identify the relevant studies from PubMed and Embase. Fixed or random effects model was selected based on heterogeneity test. Publication bias was estimated using Begg's funnel plots and Egger's regression test.
  
  
  RESULTS
  A total of 10, 3, and 3 studies were included in the analyses of the association between ApoB-100 XbaI, EcoRI, or insertion/deletion (ID) polymorphisms and the GS risks, respectively, while 3 studies were included in the analysis for the association between XbaI polymorphism and GBC risk. The combined results showed a significant association in Chinese (X+ vs. X-, OR = 2.37, 95%CI 1.52-3.70; X+X+/X+X- vs. X+X+, OR = 2.47, 95%CI 1.55-3.92), but not in Indians or Caucasians. Null association was observed between EcoRI or ID polymorphisms and GS risks. With regard to the association between XbaI polymorphism and GBC risk, a significant association was detected when GBC patients were compared with healthy persons and when GBC patients were compared with GS patients. A significant association was still detected when GBC patients (with GS) were compared with the GS patients (X+X+ vs. X-X-, OR = 0.33, 95%CI 0.12-0.90).
  
  
  CONCLUSIONS
  The results of this meta-analysis suggest that the ApoB-100 X+ allele might be associated with increased risk of GS in Chinese but not in other populations, while the ApoB-100 X+X+ genotype might be associated with reduced risk of GBC. Further studies with larger sample sizes are needed to confirm these results.
authors: Institute of Hepatopancreatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing City, PR China.
authors: Yi
authors: Y
authors: Gong
authors: Leida
authors: L
authors: Zhang
authors: Ping
authors: P
authors: Bie
authors: Huaizhi
authors: H
authors: Wang
mesh_terms: D053299:Apolipoprotein B-100 / Q000235:genetics*; D044466:Asian People / Q000235:genetics; D005706:Gallbladder Neoplasms / Q000208:ethnology / Q000235:genetics*; D042882:Gallstones / Q000208:ethnology / Q000235:genetics*; D006801:Humans; D011110:Polymorphism, Genetic; D012306:Risk; D044465:White People / Q000235:genetics
chemical_list: D053299:Apolipoprotein B-100
references: World J Gastroenterol. 2010 Oct 7;16(37):4685-90
references: 20872969
references: Clin Res Hepatol Gastroenterol. 2012 Apr;36(2):122-9
references: 21978438
references: Stat Med. 2006 Oct 30;25(20):3443-57
references: 16345038
references: J Lipid Res. 2009 Apr;50 Suppl:S189-94
references: 19064999
references: Hum Genet. 2004 Feb;114(3):280-3
references: 14618390
references: Lancet. 2006 Jul 15;368(9531):230-9
references: 16844493
references: Clin Genet. 1996 Nov;50(5):339-47
references: 9007321
references: PLoS One. 2013;8(1):e54188
references: 23335995
references: Zhonghua Yi Xue Za Zhi. 1999 Sep;79(9):673-5
references: 11715456
references: Subcell Biochem. 2010;51:279-318
references: 20213548
references: Mol Biol Rep. 2009 May;36(5):1015-21
references: 18512131
references: Liver Int. 2007 Sep;27(7):1008-15
references: 17696941
references: J Lipid Res. 2009 Apr;50 Suppl:S406-11
references: 19017613
references: CA Cancer J Clin. 2001 Nov-Dec;51(6):349-64
references: 11760569
references: Stat Med. 2002 Jun 15;21(11):1539-58
references: 12111919
references: Hepatology. 2005 Oct;42(4):894-904
references: 16175613
references: Arch Med Res. 2007 Apr;38(3):360-3
references: 17350490
references: Nat Rev Cancer. 2004 Sep;4(9):695-706
references: 15343276
references: Curr Opin Lipidol. 2004 Jun;15(3):279-86
references: 15166783
references: Indian J Clin Biochem. 2008 Apr;23(2):123-9
references: 23105737
references: Front Biosci. 2003 Sep 01;8:s1166-74
references: 12957839
references: J Gastroenterol Hepatol. 2010 Nov;25(11):1758-62
references: 21039838
references: PLoS One. 2012;7(9):e45849
references: 23049877
references: World J Gastroenterol. 1998 Aug;4(4):337-339
references: 11819315
references: J Lipid Res. 1995 Apr;36(4):804-12
references: 7616125
references: Zhonghua Yi Xue Za Zhi. 2003 May 25;83(10):844-7
references: 12895336
references: J Lipid Res. 1990 Jul;31(7):1255-61
references: 1698214
references: Curr Gastroenterol Rep. 2005 May;7(2):132-40
references: 15802102
references: Arteriosclerosis. 1989 Jan-Feb;9(1):96-108
references: 2912424
references: Arterioscler Thromb. 1994 Apr;14(4):527-33
references: 7908536
references: World J Gastroenterol. 2004 May 15;10(10):1508-12
references: 15133863
references: World J Gastroenterol. 2010 Jan 21;16(3):372-8
references: 20082485
references: Carcinogenesis. 2011 Jan;32(1):58-62
references: 21062971
references: J Intern Med. 2007 Jun;261(6):529-42
references: 17547709
references: PLoS One. 2012;7(9):e46632
references: 23029558
references: Physiol Res. 2001;50(4):337-43
references: 11551138
references: Atherosclerosis. 1988 Nov;74(1-2):47-54
references: 2905601
references: Nat Genet. 2007 Aug;39(8):995-9
references: 17632509
references: Int J Biol Macromol. 2009 Mar 1;44(2):138-42
references: 19059430
references: J Assoc Acad Minor Phys. 2001 Jul;12(3):137-43
references: 11858192